Breaking News

SGD Pharma to Acquire Alphial S.r.l.

Will enhance SGD Pharma’s capabilities and expand its market presence in Europe.

SGD Pharma, a provider of Pharmaceutical Glass Packaging, has agreed to acquire Alphial S.r.l., a producer of Tubular Vials and Ampoules headquartered in Italy. This strategic acquisition will enhance SGD Pharma’s capabilities and expand its market presence in Europe.

Alphial S.r.l. is a tubular glass converting company manufacturing ampoules, vials and Ready To Use (RTU) products. The company employs more than 220 people across four manufacturing sites in Italy.

“We are excited to welcome Alphial S.r.l. to the SGD Pharma family,” said Olivier Rousseau, CEO of SGD Pharma. “This acquisition represents a significant milestone in our growth strategy and will enable us to better serve our clients with an expanded portfolio of services and solutions.”

The acquisition of Alphial S.r.l. by SGD Pharma is subject to the Italian FDI clearance. The integration process will begin after the closing.

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters